Usman Malik has been promoted to Deputy Director – Metabolic Portfolio at CCL Pharmaceuticals

Usman Malik has been promoted to Deputy Director – Metabolic Portfolio at CCL Pharmaceuticals, marking a significant progression in his pharmaceutical commercial leadership journey and further strengthening his role in driving portfolio growth and strategic market development.

With extensive experience across sales, marketing, brand strategy, and product management, Usman brings a strong track record of leading diverse therapeutic portfolios and driving impactful commercial initiatives. His professional journey reflects expertise in diabetes, cardiology, obesity, dyslipidemia, hypertension, and heart failure, along with experience in successful product launches, market expansion, portfolio development, and strategic brand management.

Usman holds an MBA in Marketing from Coventry University and a Doctor of Pharmacy (Pharm.D.) from Baqai Medical University. Combining strong pharmaceutical expertise with strategic business and marketing acumen, he brings a well-rounded perspective to his expanded leadership role and continued contribution to commercial growth in the healthcare sector.